| Literature DB >> 23883526 |
Mary Sekiya1, Annetta Zintl, Michael L Doherty.
Abstract
The bulk milk enzyme-linked immune sorbent assay (ELISA) is a rapid and inexpensive method of assessing herd exposure to pathogens that is increasingly being used for the diagnosis of parasite infections in dairy herds. In this paper, with the dairy herd health veterinarian in mind, we review the principles of the assay and the recent literature on the potential role of bulk milk ELISA for the diagnosis of ostertagiosis, fasciolosis, parasitic bronchitis due to cattle lung worm and neosporosis. It is generally accepted that assay results reflect exposure to the parasite rather than the presence of active infection. Bulk milk ELISA can be a useful tool for the veterinary practitioner as a component of a herd health monitoring programme or in the context of a herd health investigation. It can also play a role in regional or national surveillance programmes. However, the results need to be interpreted within the context of the herd-specific health management, the milk production pattern and the parasite life cycle.Entities:
Year: 2013 PMID: 23883526 PMCID: PMC3733751 DOI: 10.1186/2046-0481-66-14
Source DB: PubMed Journal: Ir Vet J ISSN: 0368-0762 Impact factor: 2.146
Explanation of the terminology used in this review
| Gold standard | A perfect definitive test that produces no misclassifications |
| Sensitivity | Probability of a positive test result given the animal is truly infected |
| Specificity | Probability of a negative test result given the animal is truly not infected |
| Titre | The highest dilution of the sample at which the test is still positive |
| Optical density (OD) | Colour (absorbance) change in a sample resulting from the conversion of substrate and measured using spectrophotometry |
| Cut-off OD value | The absorbance above which samples are considered positive |
| Receiver operator characteristic | Statistical method used to calculate cut-off OD values |
| Sample to positive (SP) ratio or Optical density ratio (ODR) | The ratio of the OD of the sample to the OD of the positive control (SP ratio = ODsample/ODpositive control) |
| Percent positivity (PP) | Sample to positive ratio x100 |
prevalence based on bulk milk assay
| Belgium | Conventional 1,800 | 59.1% (95% CI, 56.8-61.4%) | [ |
| Sweden | Organic 113 | 0.82% (95% CI, 0.78-0.86%) | [ |
| Conventional 113 | 0.66% (95% CI, 0.61-0.71%) |
Mean optical density ratios (ODR) for based on bulk milk assay
| Denmark | 146/146 | 0.48 | [ |
| Germany | 78/131 | 0.48 | [ |
| Italy | 47/140 | 0.31 | [ |
| Netherlands | 243/288 | 0.45 | [ |
| Portugal | 92/163 | 0.61 | [ |
| Spain | 91/143 | 0.53 | [ |
| UK/Ireland | 142/174 | 0.60 | [ |
Performance characteristics and minimum within-herd prevalence for four ELISA kits
| IDEXX- Institut Pourquier | Fraction f2 of ES | 95%a | 98.2%a | 20%b | IDEXX | a[ |
| b[ | ||||||
| MM3-SERO | Monoclonal Ab sens. wells treated with purified protein | 100%c | 100%c | 12%d | Bio-X | c[ |
| d[ | ||||||
| LSTM ES-ELISA | ES fraction | 98% (95%CI 96–100%)e | 96% (95% CI 93–98%)e | 25%f | In-house | e[ |
| f[ |
prevalence based on bulk milk assay and in comparison to faecal analysis (where available)
| England | 623 | 48% | | [ |
| Wales | 445 | 86% | | |
| England | 60 | 53% | 17% (of pooled samples examined by standard sedimentation) | [ |
| Belgium | 1,800 | 37% (95%CI: 35-40%) | | [ |
| Sweden | 113 (organic) | 7% | | [ |
| | 113 | 6% | | |
| Austria | 31 | 58% (Euroclone ELISA) | 65% by sedimentation | [ |
| | | 61% (Pourquier ELISA) | 55% by coproantigen ELISA | |
| Germany | 4630 | 51% | [ |
* All herds under conventional management unless otherwise indicated.
prevalence based on bulk milk assay
|
| |||
|---|---|---|---|
| Belgium | 1,800 | 19.6% | [ |
| Sweden | Organic herds 113 | 18% | [ |
| | Conventional 113 | 9% | |
| Germany (East Frisia) | 906 | 12.8% Jan 07 | [ |
| 6.9% Sept 08 | |||
| 6.6% Nov 08 |
ELISA assays for the detection of in cattle bulk milk samples
| ISCOM ELISA (Boehringer Ingelheim Svanova, Uppsala Sweden) | Tachyzoite antigen mixed with iscoms 1 | 50% | 81% | [ |
| (21-79%) | (72-89%) | | ||
| IDEXX | Whole sonicated tachyzoites | 61% | 92% | [ |
| (49-73%) | (87-98%) | | ||
| LSI ELISA (Lissieu, France) | Whole tachyzoite crude antigen lysate | 47% | 94% | [ |
| (35-60%) | (90-99%) | | ||
| Mastazyme® ELISA (Mast Diagnostics UK) | Whole tachyzoites | 61-78% | 75-96% | [ |
| BioK 192/5, Jemelle, Belgium | Recombinant NcSRS2 protein | 95% | 96% | [ |
1 Immunostimulatory complex composed of quillaja saponin, cholesterol and phospholipids.
prevalence based on bulk milk assay
| Thailand (North and Northeast) | 220 | 46% | [ |
| Sweden | 2,978 | 8.3% (95% CI, 7.3–9.3%) | [ |
| Norway | 1,657 | 0.7% (95% CI, 0.3–1.2%) | [ |
| Canada | 235- May 04 | 6.4% | [ |
| 189- May 05 | 10.1% | ||
| 235- June 05 | 10.2% | ||
| Australia (South) | 122 | 2.5% (95% CI, 1.4–3.6%) | [ |
| Spain (Galicia) | 276 | 56% | [ |
Figure 1The herd health management cycle, adapted from Mulligan et al. [82].